Selcia Limited Doubles Capacity of 14C GMP Radiolabelled API Production for Human Studies  
11/29/2011 9:30:46 AM

ONGAR, England--(BUSINESS WIRE)--Selcia has successfully completed 14C radiolabelled API projects on behalf of a diverse range of clients for phase 1 human trials, following MHRA GMP Certification in September 2010. In response to a sharp increase in demand for this specialist service, Selcia has invested to double its capacity for handling GMP radiolabelling projects.